New emerging targets in cancer immunotherapy: the role of TIM3

• Alex Friedlaender,
• Alfredo Addeo,
• Giuseppe Banna

Affiliations

Alex Friedlaender

3 Department of Oncology, University Hospital of Geneva, Geneva, Switzerland

Alfredo Addeo

3 Department of Oncology, University Hospital of Geneva, Geneva, Switzerland

Giuseppe Banna

1 Oncology, Ospedale Cannizzaro, Catania, Italy